Navigation Links
Elekta Announces First Two Clinical Sites Using VMAT Cancer Treatment Capability
Date:1/18/2008

ATLANTA, Jan. 18 /PRNewswire/ -- Elekta, a world leader in clinical solutions for radiation therapy and radiosurgery, announced today that two sites are utilizing Elekta technology to implement clinical treatments with Volumetric Modulated Arc Therapy (VMAT)*. With the recent CE designation of VMAT in Europe, the way has been cleared for The Royal Marsden Hospital in Sutton, UK and General Hospital Vienna in Austria to treat cancer using Elekta's VMAT solution.

VMAT is a significant improvement to existing advanced radiation therapy techniques, often referred to as IMRT (Intensity Modulated Radiation Therapy) and offers a faster alternative to helical tomotherapy. With Elekta's VMAT technology, the target continuously is radiated while the source of the beam is rotated around the patient in single or multiple arcs. By simultaneously controlling gantry position, gantry speed, leaves of the multi-leaf collimator (MLC), collimator angle and dose rate, a highly conformal dose distribution is created in significantly less time than with today's techniques. With VMAT from Elekta, a treatment session typically can be conducted in five minutes or less, including true 3D imaging to secure the location of the target.

"VMAT is a very promising technique," says Dietmar Georg, Ph.D., head of the Division of Medical Radiation Physics, Department of Radiotherapy, Medical University Vienna/General Hospital Vienna. "The rotational therapy and intensity modulation results in improved dose distribution and high conformality for optimal sparing of normal tissue." Using VMAT, Dr. Georg expects to see a more efficient workflow and faster treatments for patients receiving advanced radiotherapy.

Jim Warrington, head of Radiotherapy Physics at The Royal Marsden Hospital, says, "With the potential to produce megavoltage X-ray treatments of the highest quality and efficiency available, we anticipate VMAT will offer us greater flexibility as a radiotherapy treatment option."

Both sites have installed necessary system updates, and are eagerly anticipating the first VMAT treatments by the end of January.

Elekta leads the way with dynamic VMAT package

Elekta's solution for VMAT treatments is a complete package that includes MOSAIQ(TM), an image-enabled oncology Electronic Medical Records (EMR) system that supports each member of the cancer care team. The package also contains ERGO++ the first treatment planning system to employ inverse-planning techniques for rotational IMRT. When combined with existing digital linear accelerators, this system provides a simple, innovative solution for clinical VMAT cancer treatment.

As VMAT technology becomes the new standard in cancer care, Elekta continues to lead the way with advanced solutions for treating serious disease.

*Elekta Volumetric Intensity Modulated Arc Therapy (VMAT) is pending regulatory approvals in certain markets, including 510(k) clearance in the US, and is not yet for commercial sale in the US

About Elekta

Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and information systems as well as services for improved cancer care and management of brain disorders.

Elekta's systems and solutions are used in over 4,500 hospitals around the world. Clinical and information management solutions include, among others, Leksell Gamma Knife(R) for non-invasive treatment of brain disorders, Elekta Axesse(TM) and Elekta Synergy(R) for stereotactic and image guided radiation therapy and radiosurgery as well as the MOSAIQ(TM) suite of software for image-enabled EMR and efficient management of clinical and patient data.

With over 2,000 employees globally, the corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information about Elekta can be found at http://www.elekta.com.


'/>"/>
SOURCE Elekta, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Elekta Announces Clinical Start-up of Elekta Synergy(R) S at UPMC
2. Elekta Negotiates To Acquire CMS
3. Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
4. Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
5. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
6. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
7. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
8. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
9. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
10. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
11. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... LOS ANGELES, Calif. (PRWEB) , ... April 27, ... ... Los Angeles office of Lewis Roca Rothgerber Christie LLP as an associate in ... and prosecuting U.S. and international electrical, mechanical and electromechanical patent applications. He has ...
(Date:4/26/2016)... ... 2016 , ... Heidelberg Instruments, a leader in design, development ... Volume Pattern Generator (VPG) line of lithography systems. The breakthrough VPG+ system is ... a solution for mid volume direct write lithography applications. It utilizes the ...
(Date:4/26/2016)... ... 26, 2016 , ... BioFactura, Inc ., a biopharmaceutical research and manufacturing ... Healthy investor interest drove significant oversubscription of the original $1.5M target. The funds ... the advanced preclinical stages. , Chief Executive Officer and President, Darryl Sampey ...
(Date:4/26/2016)... ... ... uBiome, the leading microbial genomics company, welcomes Neil Grimmer, Co-founder and Chairman ... co-founding Plum in 2007, Neil Grimmer was Vice President of Strategy and Innovation at ... of ideas, products, and brands, Grimmer has been at the forefront of launching more ...
Breaking Biology Technology:
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
(Date:3/18/2016)... March 18, 2016 --> ... Biometrics, ICT, Manned & Unmanned Vehicles, Physical infrastructure and Perimeter ... companies in the border security market and the continuing migration ... Europe has led visiongain to publish ... success. --> defence & security companies in ...
(Date:3/15/2016)... JERUSALEM , March 15, 2016 ... Jerusalem , the technology-transfer company of the Hebrew University, ... developer of remote sensing technology of various human biological ... funding, raising $2.0 million from private investors. ... technology, based on the detection of electromagnetic emissions from ...
Breaking Biology News(10 mins):